Fitusiran Curbs Bleeds in Hemophilia A, B With Inhibitors, Data Show
When given monthly to people with hemophilia A or B with inhibitors, fitusiran significantly reduced bleeding, and for some, fully eliminated them, according to data from the Phase 3 ATLAS-INH study.